Koers Nutralife Biosciences Inc Other OTC
Aandelen
US67091B1044
Farmaceutische producten
Omzet 2020 | 1,26 mln. 1,17 mln. | Omzet 2021 | 627K 586K | Marktkapitalisatie | 13,01 mln. 12,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2021 | -5 mln. -4,68 mln. | EV/omzet 2020 | 14,5 x |
Nettoschuld 2020 | 3,16 mln. 2,95 mln. | Nettoschuld 2021 | 3,01 mln. 2,81 mln. | EV/omzet 2021 | 25,6 x |
K/w-verhouding 2020 |
-4,81
x | K/w-verhouding 2021 |
-2,18
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 54,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edgar Ward
FOU | Founder | 52 | 01-04-10 |
Nicholas Ward
COO | Chief Operating Officer | - | 01-04-10 |
Nicole Archon
AUD | Comptroller/Controller/Auditor | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edgar Ward
FOU | Founder | 52 | 01-04-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |